Literature DB >> 18095943

IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.

Ralf Müller1, Vera Svoboda, Elke Wenzel, Hans-Helge Müller, Michael Hertl.   

Abstract

Pemphigus vulgaris (PV) is associated with autoantibodies against desmoglein (Dsg) 3 inducing epidermal loss of adhesion. The major pathogenic epitopes of Dsg3 are presumably dependent of their conformation. The aim of this study was to characterize the IgG reactivity of sera from a cohort of clinically well-characterized PV patients against presumably non-conformational subdomains of the Dsg3 ectodomain including recently described NH2-terminal immunodominant epitopes. By ELISA, IgG reactivity against distinct subdomains of Dsg3 was related to disease activity and the clinical phenotype of PV patients. Our findings suggest that (i) autoantibody from PV sera react with non-conformational epitopes of Dsg3; (ii) IgG reactivity against the NH2-terminus and the extracellular domains (EC) 2-4 of Dsg3 was associated with active PV, while IgG titres were not strictly correlated with disease activity and (iii) IgG reactivity against the EC1-4 was associated with mucosal dominant PV and was decreased in cutaneous dominant PV. The findings may help to define more refined serological disease markers of PV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095943     DOI: 10.1111/j.1600-0625.2007.00615.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

1.  IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion.

Authors:  David Rafei; Ralf Müller; Norito Ishii; Maria Llamazares; Takashi Hashimoto; Michael Hertl; Rüdiger Eming
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Respiratory function in patients with pemphigus vulgaris - a small clinical study.

Authors:  Zoi Apalla; Diamantis Chloros; Paraskevi Argyropoulou; Dimitrios Georgopoulos; Dimitrios Patakas; Dimitrios Spanos; George Chaidemenos
Journal:  J Dermatol Case Rep       Date:  2011-03-26

3.  Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.

Authors:  Giovanni Di Zenzo; Giulia Di Lullo; Davide Corti; Valentina Calabresi; Anna Sinistro; Fabrizia Vanzetta; Biagio Didona; Giuseppe Cianchini; Michael Hertl; Rudiger Eming; Masayuki Amagai; Bungo Ohyama; Takashi Hashimoto; Jerry Sloostra; Federica Sallusto; Giovanna Zambruno; Antonio Lanzavecchia
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

4.  Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris.

Authors:  Ralf Müller; Nicolas Hunzelmann; Vera Baur; Guido Siebenhaar; Elke Wenzel; Rüdiger Eming; Andrea Niedermeier; Philippe Musette; Pascal Joly; Michael Hertl
Journal:  Dermatol Res Pract       Date:  2010-06-30

Review 5.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

6.  Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence.

Authors:  Mariko Yokouchi; Marwah Adly Saleh; Keiko Kuroda; Takahisa Hachiya; John R Stanley; Masayuki Amagai; Ken Ishii
Journal:  J Invest Dermatol       Date:  2009-04-02       Impact factor: 8.551

Review 7.  The desmosome and pemphigus.

Authors:  Jens Waschke
Journal:  Histochem Cell Biol       Date:  2008-04-03       Impact factor: 4.304

8.  Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus.

Authors:  Tina Hennerici; Robert Pollmann; Thomas Schmidt; Maria Seipelt; Björn Tackenberg; Christian Möbs; Kamran Ghoreschi; Michael Hertl; Rüdiger Eming
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

9.  The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab.

Authors:  Marie-Laure Golinski; Alexandre Lemieux; Maud Maho-Vaillant; Marion Barray; Laurent Drouot; Damien Schapman; Marie Petit; Michael Hertl; Olivier Boyer; Sébastien Calbo; Pascal Joly; Vivien Hébert
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.